euSPRI

Advertisement

IDEM

Advertisement

Enid

Advertisement

IJCEE - edited by Ceris

Advertisement

IJATM - edited by Ceris

Advertisement

S. & T. in cifre 2014

Advertisement

Ceris Newsletter

Advertisement

Home

-

Pubblicazioni Ceris

Anno/Year
2012
Autori/Authors
Falavigna G., Ippoliti R.
Rivista/Journal
Titolo/Title
Pharmaceutical clinical research and regulation: an impact evaluation of public policy
Libro/Book
Technical Report
Polis working paper
Conference
Editor
City
Volume
195
Pages
Research
Imprese e struttura Industriale
Abstract
Taking human experimentation into account, this work aims at estimating a policy designed to reduce transaction costs that are related to the protection system of patients’ rights, with both a normative and positive approach. On the one hand, considering a sample of European countries as counterfactual, an empirical analysis is performed in order to estimate the impact of a national law aimed at harmonizing the procedure to obtain opinions on clinical trials. On the other hand, an alternative law, which might be able to favor the exchange between pharmaceutical companies and patients, is proposed. Assuming that the competitiveness of the national protection system is based on the time required to obtain an authorization for an experimental activity, pharmaceutical clinical research should be positively affected by a reform of the current law. However, there is also evidence of a wasted opportunity to optimize the governance of the national protection system.

tipo - [joined to Pubblicazioni Ceris]

Tipo/Typology
Other Publications
© 2021 Ceris - CNR
Joomla! is Free Software released under the GNU/GPL License.

CSS Valido!

>